Skip to content

Location of cystic lesion and the Incidence of Pancreatic Cancer Concomitant with Intraductal Papillary Mucinous Neoplasm(IPMN)

Location of cystic lesion and the Incidence of Pancreatic Cancer Concomitant with Intraductal Papillary Mucinous Neoplasm(IPMN) - Cyst location and pancreatic cancer with IPMN

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000026262
Enrollment
164
Registered
2017-02-22
Start date
2016-11-09
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

intraductal papillary mucnous neoplasm

Interventions

None listed

Sponsors

Division of Gastroenterology, Department of Internal medicine, Kobe University Graduate School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: more than 20 years old

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The relationship between location of cystic lesion and the Incidence of Pancreatic Cancer Concomitant with IPMN

Secondary

MeasureTime frame
The relationship between family history of pancreatic cancer, diabetes mellitus, alcohol consumption, BMI and smoking history, and the incidence of IPMN with an associated invasive carcinoma or pancreatic cancer concomitant with IPMN

Countries

Japan

Contacts

Public ContactAtsuhiro Masuda

Kobe University Hospital Dep. of Gastroenterology

atmasuda@med.kobe-u.ac.jp078-382-6305

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026